KYLE ECHOLS: Open Payments
NPI 1427135946 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$817 in 34 payments from 14 companies in 2025. Trend: 2023 $716 · 2024 $901 · 2025 $817
Food & beverage: $817
| Company | Payments | Amount |
|---|---|---|
| Corium, LLC | 6 | $143 |
| Supernus Pharmaceuticals, Inc. | 4 | $113 |
| Otsuka America Pharmaceutical, Inc. | 4 | $101 |
| Vanda Pharmaceuticals Inc. | 3 | $87 |
| Axsome Therapeutics, Inc. | 3 | $83 |
| ABBVIE INC. | 4 | $80 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $55 |
| Janssen Pharmaceuticals, Inc | 2 | $31 |
| Lundbeck LLC | 1 | $27 |
| Tris Pharma Inc | 1 | $25 |
Products named: Azstarys, Qelbree, REXULTI, FANAPT, Auvelity, VRAYLAR, TRINTELLIX, SPRAVATO.
Industry payments across AL — which companies pay providers there.
